Hellenic Cooperative Oncology Group

This study looked at how safe and effective two targeted drugs, trastuzumab deruxtecan and sacituzumab govitecan, are for people with advanced breast cancer. Researchers reviewed medical records of 312 patients who had already tried other treatments. The goal was to see side effe…

This study analyzed information from over 5,000 people with early-stage breast cancer who received a specific type of chemotherapy called dose-dense sequential chemotherapy. The goal was to see how long they lived without the cancer coming back and what side effects they had. Thi…

This study looked at immune cells (called TILs and CD8+ T cells) in tumor samples from over 3,600 women with early-stage breast cancer who had chemotherapy after surgery. The goal was to see if these cells are linked to how long patients live without the cancer coming back. The f…

This study looked at tumor samples from 687 women with advanced high-grade serous ovarian cancer to see if certain immune cells (like T cells and plasma cells) are linked to how well patients do. Researchers checked for structures called tertiary lymphoid structures and a protein…

This study looked at tissue samples from 2751 women with early breast cancer who had already been treated with chemotherapy. The goal was to compare tumors with very low HER2 levels (HER2-low) to those with none (HER2-zero) to see if they behave differently. Researchers hope this…